Autolus closes on EU okay for leukaemia cell therapy
Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been recommended for conditional approval in the EU. The EMA's human medicines committee, the CHMP, has issued a positive opinion of …